IGUCHI KIMI 4
4 · Sage Therapeutics, Inc. · Filed Nov 30, 2023
Insider Transaction Report
Form 4
IGUCHI KIMI
See Remarks
Transactions
- Tax Payment
Common Stock
2023-11-28$19.27/sh−943$18,172→ 68,787 total - Award
Common Stock
2023-11-28+3,500→ 69,730 total
Footnotes (2)
- [F1]On March 25, 2020, the reporting person was granted Performance Stock Units (PSUs) to acquire a total of 8,750 shares of common stock. The PSUs vest upon the achievement of certain milestones, one of which was met on November 28, 2023, resulting in the vesting of the PSUs as to 3,500 shares.
- [F2]Reflects beneficial ownership balance which includes 670 shares purchased on June 30, 2023 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.